Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
Despite the recent successes in siRNA therapeutics, targeted delivery beyond the liver remains the major hurdle for the widespread application of siRNA in vivo. Current cationic liposome or polymer-based delivery agents are restricted to the liver and suffer from off-target effects, poor clearance,...
Saved in:
Main Authors: | Xiaolin Yu (Author), Lu Xue (Author), Jing Zhao (Author), Shuhua Zhao (Author), Daqing Wu (Author), Hong Yan Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain
by: Taejin Kim, et al.
Published: (2020) -
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
by: Tomoya Hada, et al.
Published: (2015) -
Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan
by: Lin Li, et al.
Published: (2017) -
Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extension
by: Xinyang Zhou, et al.
Published: (2021) -
A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo
by: Shuai He, et al.
Published: (2017)